Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis

Abstract The Bradford Hill model evaluates the causal inference of one variable on another by assessing whether evidence of the suspected causal variable aligns with a set of nine criteria proposed by Bradford Hill, each representing fundamental tenets of a causal relationship. The aim of this study...

Full description

Bibliographic Details
Main Authors: Amr H. Abdeen, Benjamin G. Trist, Kay L. Double
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-022-00345-4
_version_ 1827614309194137600
author Amr H. Abdeen
Benjamin G. Trist
Kay L. Double
author_facet Amr H. Abdeen
Benjamin G. Trist
Kay L. Double
author_sort Amr H. Abdeen
collection DOAJ
description Abstract The Bradford Hill model evaluates the causal inference of one variable on another by assessing whether evidence of the suspected causal variable aligns with a set of nine criteria proposed by Bradford Hill, each representing fundamental tenets of a causal relationship. The aim of this study was to use the Bradford Hill model of causation to assess the level of empirical evidence supporting our hypotheses that alterations to iron and copper levels, and iron- and copper-associated proteins and genes, contribute to Parkinson’s disease etiology. We conducted a systematic review of all available articles published to September 2019 in four online databases. 8437 articles matching search criteria were screened for pre-defined inclusion and exclusion criteria. 181 studies met study criteria and were subsequently evaluated for study quality using established quality assessment tools. Studies meeting criteria for moderate to high quality of study design (n = 155) were analyzed according to the Bradford Hill model of causation. Evidence from studies considered of high quality (n = 73) supported a causal role for iron dysregulation in Parkinson’s disease. A causal role for copper dysregulation in Parkinson’s disease was also supported by high quality studies, although substantially fewer studies investigated copper in this disorder (n = 25) compared with iron. The available evidence supports an etiological role for iron and copper dysregulation in Parkinson’s disease, substantiating current clinical trials of therapeutic interventions targeting alterations in brain levels of these metals in Parkinson’s disease.
first_indexed 2024-03-09T08:53:03Z
format Article
id doaj.art-5bcfbed266bc4ea58c4afce7e0cd8331
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-09T08:53:03Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-5bcfbed266bc4ea58c4afce7e0cd83312023-12-02T13:46:17ZengNature Portfolionpj Parkinson's Disease2373-80572022-06-018111110.1038/s41531-022-00345-4Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysisAmr H. Abdeen0Benjamin G. Trist1Kay L. Double2Brain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, CamperdownBrain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, CamperdownBrain and Mind Centre and School of Medical Sciences (Neuroscience), Faculty of Medicine and Health, The University of Sydney, CamperdownAbstract The Bradford Hill model evaluates the causal inference of one variable on another by assessing whether evidence of the suspected causal variable aligns with a set of nine criteria proposed by Bradford Hill, each representing fundamental tenets of a causal relationship. The aim of this study was to use the Bradford Hill model of causation to assess the level of empirical evidence supporting our hypotheses that alterations to iron and copper levels, and iron- and copper-associated proteins and genes, contribute to Parkinson’s disease etiology. We conducted a systematic review of all available articles published to September 2019 in four online databases. 8437 articles matching search criteria were screened for pre-defined inclusion and exclusion criteria. 181 studies met study criteria and were subsequently evaluated for study quality using established quality assessment tools. Studies meeting criteria for moderate to high quality of study design (n = 155) were analyzed according to the Bradford Hill model of causation. Evidence from studies considered of high quality (n = 73) supported a causal role for iron dysregulation in Parkinson’s disease. A causal role for copper dysregulation in Parkinson’s disease was also supported by high quality studies, although substantially fewer studies investigated copper in this disorder (n = 25) compared with iron. The available evidence supports an etiological role for iron and copper dysregulation in Parkinson’s disease, substantiating current clinical trials of therapeutic interventions targeting alterations in brain levels of these metals in Parkinson’s disease.https://doi.org/10.1038/s41531-022-00345-4
spellingShingle Amr H. Abdeen
Benjamin G. Trist
Kay L. Double
Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
npj Parkinson's Disease
title Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
title_full Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
title_fullStr Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
title_full_unstemmed Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
title_short Empirical evidence for biometal dysregulation in Parkinson’s disease from a systematic review and Bradford Hill analysis
title_sort empirical evidence for biometal dysregulation in parkinson s disease from a systematic review and bradford hill analysis
url https://doi.org/10.1038/s41531-022-00345-4
work_keys_str_mv AT amrhabdeen empiricalevidenceforbiometaldysregulationinparkinsonsdiseasefromasystematicreviewandbradfordhillanalysis
AT benjamingtrist empiricalevidenceforbiometaldysregulationinparkinsonsdiseasefromasystematicreviewandbradfordhillanalysis
AT kayldouble empiricalevidenceforbiometaldysregulationinparkinsonsdiseasefromasystematicreviewandbradfordhillanalysis